Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Immunovant Inc (IMVT)

210 + Investors. Track Smart Money conviction in IMVT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +16
Streak
3Q ▲
Buyers last Q
66%

Smart Money Signals — IMVT

Based on 212 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added IMVT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (95% of max)

95% of all-time peak
212 hedge funds hold IMVT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+14 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction. The peak was reached in just 2 quarters from the low — a sharp move.
🟢

More buyers than sellers — 66% buying

140 buying72 selling
Last quarter: 140 funds were net buyers (43 opened a brand new position + 97 added to an existing one). Only 72 were sellers (45 trimmed + 27 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~43 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 23 → 31 → 41 → 43. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

53% of holders stayed for 2+ years

■ 53% conviction (2yr+) ■ 27% medium ■ 20% new
112 out of 212 hedge funds have held IMVT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

39 → 23 → 31 → 41 → 43 new funds/Q
New funds entering each quarter: 23 → 31 → 41 → 43. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 65% veterans vs 24% newcomers

■ 65% veterans ■ 11% 1-2yr ■ 24% new
Entry-cohort mix of 223 holders: 145 (65%) are 2+ year veterans, 24 entered 1–2 years ago, and 54 (24%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 42% AUM from top-100 funds

42% from top-100 AUM funds
44 of 211 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in IMVT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IMVT

In 2026 Q1, 140 hedge funds were net buyers of IMVT (43 opened a new position, 97 added to an existing one), while 72 reduced or exited (45 trimmed, 27 sold completely) — a 66% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 42% of total institutional value in IMVT is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +16 funds (more new holders than closures). Total institutional holders: 212.

Hedge Fund Ownership: IMVT

How many hedge funds hold IMVT — quarterly history vs. share price
Quarterly hedge fund ownership of IMVT vs. share price

Market Analysis: IMVT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IMVT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Immunovant Inc (IMVT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IMVT has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 45d ago
IMVT
+10.4%
XLV
+6.1%

IMVT outperformed XLV by +4.3% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 0d ago
IMVT
+0.0%
XLV
+0.0%

Since the filing became public, IMVT outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

24 top-rated funds 8 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
4.7
/ 10
conviction
Hedge Fund Positioning: IMVT
2026 Q2 Stats Unlock in 5 days 210 + Investors

Track Smart Money conviction in IMVT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 210 196 7.14%
13F Shares 113M 106M 7.23%
Total Value $2.70B $2.66B 1.67%
New Positions 41 41 -
Increased Positions 92 76 +16
Closed Positions 27 29 -2
Reduced Positions 43 54 -11
Total Calls 6 8 -25.0%
Total Puts 6 6 -
PUT/CALL Ratio 1.0 0.75 Neutral

Statistics: IMVT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

210 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMVT. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 IMVT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Silverarc Capital Management, LLC 2.48% 619,096 $23.9M
2 Two Seas Capital LP 2.40% 3,148,505 $121.3M
3 Tetragon Partners GP Ltd 1.55% 255,934 $9.9M
4 Platinum Investment Management Ltd 1.37% 144,671 $5.6M
5 Alchemi Wealth, LLC 0.84% 46,500 $1.8M
6 Informed Momentum Co LLC 0.44% 127,273 $4.9M
7 Soleus Capital Management, L.P. 0.33% 252,000 $9.7M
8 PSP Research LLC 0.27% 13,000 $501K
9 Fox Run Management, L.L.C. 0.22% 34,827 $1.3M
10 Affinity Asset Advisors, LLC 0.17% 100,000 $3.9M
11 Hennion & Walsh Asset Management, Inc. 0.13% 120,686 $4.7M
12 Virtus Investment Advisers, LLC 0.09% 9,732 $375K
13 Dymon Asia Capital (singapore) PTE. LTD. 0.08% 49,805 $1.9M
14 China Universal Asset Management Co., Ltd. 0.08% 33,925 $1.3M
15 Jennison Associates LLC 0.08% 3,310,238 $127.5M
16 Arrowpoint Investment Partners (Singapore) Pte. Ltd. 0.08% 9,043 $348K
17 Algert Global LLC 0.07% 159,840 $6.2M
18 Axq Capital, LP 0.07% 16,113 $621K
19 Aberdeen Group plc 0.05% 857,030 $33.0M
20 Jump Financial, LLC 0.05% 200,835 $3.4M
21 Erste Asset Management GmbH 0.04% 144,500 $5.6M
22 Profund Advisors LLC 0.04% 36,510 $1.4M
23 Renaissance Technologies LLC 0.04% 726,800 $28.0M
24 Connor, Clark & Lunn Investment Management Ltd. 0.03% 473,984 $18.3M
25 Fmr LLC 0.03% 16,186,469 $623.7M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Immunovant Inc (IMVT)

What does the Smart Money Trend signal show for IMVT?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added IMVT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IMVT?

More buyers than sellers — 66% buying: Last quarter: 140 funds were net buyers (43 opened a brand new position + 97 added to an existing one). Only 72 were sellers (45 trimmed + 27 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IMVT holders?

Elite ownership — 42% AUM from top-100 funds: 44 of 211 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in IMVT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held IMVT?

53% of holders stayed for 2+ years: 112 out of 212 hedge funds have held IMVT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Immunovant Inc (IMVT) following the 2026 Q2 hedge fund 13F filings?

As of today, IMVT has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), IMVT has gained +10.4% vs +6.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →